Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02)

Siegel CA, Lichtenstein G, Siegmund B, Lewis JD, Wolf D, Louis E, Sebastian S, Hebuterne X, Bell A, Soderman C, Schubert S, Atreya R, Polyak S, Hoque S, Krummenerl A, Bokemeyer B, Krummenerl T, Shulmann S, Karlen P, Moum B, Dolin P (2017)


Publication Type: Conference contribution

Publication year: 2017

Journal

Book Volume: 11

Pages Range: S333-S334

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Siegel, C.A., Lichtenstein, G., Siegmund, B., Lewis, J.D., Wolf, D., Louis, E.,... Dolin, P. (2017). Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02). (pp. S333-S334).

MLA:

Siegel, C. A., et al. "Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02)." 2017. S333-S334.

BibTeX: Download